Briefs: Concord Biotech and Neuland Laboratories

Briefs: Concord Biotech and Neuland Laboratories

By: IPP Bureau

Last updated : March 23, 2024 10:38 am



The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483


Concord Biotech receives EUGMP certificate for Dholka facility

Government of Upper Franconia has Issued Certificate of Good Manufacturing Practices (EUGMP) of our Unit I (API facility) of Concord Biotech Limited, located at Trasad Road, Dholka - 382225 in Ahmedabad, Gujarat. The certificate is issued for the product "Tacrolimus Premix 20%"

Neuland Laboratories Unit 1 successfully completes USFDA inspection

Neuland Laboratories Limited has announced that the United States Food and Drug Administration (US FDA) has inspected its Unit 1 manufacturing facility at Bonthapally, Hyderabad from 18th to 22nd of March 2024.  The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483.

Concord Biotech Neuland Laboratories

First Published : March 23, 2024 12:00 am